Searched for
MANKIND PHARMA NEWS
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...
- Mankind Pharma shares jump 2% as Morgan Stanley initiates coverage with Overweight call. Check target, upsideMankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an 'Overweight' rating and a Rs 2,500 target price, citin...
- Mankind Pharma shares in focus after Q3 net profit rises 8%YoY to Rs 414 croreThe company reported an 8% year-on-year rise in Q3FY26 net profit to Rs 414 crore, while revenue grew 11.5% to Rs 3,567 crore, led by solid...
- Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 croreMankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...
- Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & VaccinesMankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccine...
- Mankind Pharma shares fall 2.5% after BSV acquisitionMankind Pharma Share Price: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Ser...
- Mankind Pharma to acquire Bharat Serums from Advent International for Rs 13,630 crMankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 ...
- Mankind Pharma is frontrunner in Bharat Serums bidMankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...
- Mankind Pharma stock falls 3% as PE investors likely sell 1.3 crore sharesPE firm ChrysCapital's affiliate entity Beige Ltd was reported to have issued a term sheet via its broker to sell up to 1.16 crore shares o...
- D-Street newbie Mankind Pharma to be included in Nifty500, Nifty Midcap100 and other indicesMankind Pharma, which recently made its stock exchange debut, has been added to several Nifty indices, including Nifty500 and Nifty Midcap1...
- Mankind Pharma shares tank over 6% a day after solid debut. Time to buy?Shares of Mankind Pharma fell more than 6%, a day after its listing on the Indian stock exchanges at a premium. The company's IPO was the l...
- 31% listing day pop! Time to book profits in Mankind Pharma shares?Its shares are currently trading nearly 6.7% higher at Rs 1,387. The IPO received a strong response, with the issue subscribed for 15.32 ti...
- Mankind Pharma shares list at 20% premium over IPO priceThe IPO, valued at Rs 4,326 crore, received an overwhelming response, being subscribed for 15.32 times due to interest from qualified insti...
- Mankind Pharma IPO: GMP rises ahead of likely share allotment tomorrow. Here's how to check statusMankind Pharma's Rs 4,326 crore initial public offering (IPO), the largest by a domestic drug maker so far in 2021 and with a 15.32 times s...
- Mankind Pharma IPO sails through on Day 3Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analys...
- Mankind Pharma IPO subscribed 14% on Day 1; GMP inches up at Rs 90-95The Rs 4,300-crore IPO, solely an offer for sale (OFS), will be available for public to bid till April 27. Investors can bid for 13 shares ...
- Mankind Pharma IPO now open: Here's how it stacks up against its peersThe Issue comprises an offer for sale (OFS) of about 40 million equity shares and will be open for subscription till April 27.
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
Load More
